These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 19210109

  • 21. Esomeprazole for the treatment of peptic ulcer bleeding.
    den Hoed CM, Kuipers EJ.
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G, Chatzinikolaou A, Kaiafa G, Savopoulos C, Hatzitolios A, Karamitsos D.
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [Abstract] [Full Text] [Related]

  • 23. Esomeprazole for asthma.
    Lenglinger J, Riegler M.
    N Engl J Med; 2009 Jul 09; 361(2):206-7; author reply 207-8. PubMed ID: 19593855
    [No Abstract] [Full Text] [Related]

  • 24. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Jul 09; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 25. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase.
    Mullin JM, Valenzano MC, Whitby M, Lurie D, Schmidt JD, Jain V, Tully O, Kearney K, Lazowick D, Mercogliano G, Thornton JJ.
    Aliment Pharmacol Ther; 2008 Dec 01; 28(11-12):1317-25. PubMed ID: 18684245
    [Abstract] [Full Text] [Related]

  • 26. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ, Smout AJ.
    Ned Tijdschr Geneeskd; 2008 Nov 22; 152(47):2548-52. PubMed ID: 19174935
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV, Viazis N, Vlachogiannakos J, Sgouros SN, Stefanidis G, Archimandritis A, Karamanolis DG.
    Am J Gastroenterol; 2010 Feb 22; 105(2):308-13. PubMed ID: 19809412
    [Abstract] [Full Text] [Related]

  • 28. [Pharma clinics medication of the month. Esomeprazole].
    Louis E.
    Rev Med Liege; 2002 Sep 22; 57(9):610-2. PubMed ID: 12440351
    [Abstract] [Full Text] [Related]

  • 29. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW.
    Ann Pharmacother; 2010 Mar 22; 44(3):572-6. PubMed ID: 20124466
    [Abstract] [Full Text] [Related]

  • 30. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA.
    Ital J Gastroenterol Hepatol; 1997 Dec 22; 29(6):569-73. PubMed ID: 9513835
    [Abstract] [Full Text] [Related]

  • 31. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL.
    Int J Clin Pract; 2002 Mar 22; 56(2):132-9. PubMed ID: 11926700
    [Abstract] [Full Text] [Related]

  • 32. Esomeprazole for the treatment of GERD in infants ages 1-11 months.
    Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2012 Jul 22; 55(1):14-20. PubMed ID: 22241513
    [Abstract] [Full Text] [Related]

  • 33. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL, Nie YQ, Hou XH, Xie PY, Fang JY, Yuan YZ, Zhou LY, Zhao NQ, Chen MH.
    J Dig Dis; 2013 Sep 22; 14(9):463-8. PubMed ID: 23659834
    [Abstract] [Full Text] [Related]

  • 34. The appropriate use of proton-pump inhibitors.
    Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Pellegatta G, Coppo C, Savarino E.
    Minerva Med; 2018 Oct 22; 109(5):386-399. PubMed ID: 29856192
    [Abstract] [Full Text] [Related]

  • 35. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C, Tvete IF, Hatlebakk JG.
    Scand J Gastroenterol; 2013 Sep 22; 48(9):1010-7. PubMed ID: 23859491
    [Abstract] [Full Text] [Related]

  • 36. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J, Jarosz M.
    J Physiol Pharmacol; 2006 Sep 22; 57 Suppl 3():143-54. PubMed ID: 17033112
    [Abstract] [Full Text] [Related]

  • 37. A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
    Cryer B.
    Am J Gastroenterol; 2006 Apr 22; 101(4):711-3. PubMed ID: 16635218
    [Abstract] [Full Text] [Related]

  • 38. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P, Staniak A, Grzegrzolka J.
    J Comp Eff Res; 2016 Mar 22; 5(2):169-78. PubMed ID: 26946951
    [Abstract] [Full Text] [Related]

  • 39. Acid pump blockers: what are their current therapeutic roles?
    Arens MJ, Dent J.
    Baillieres Clin Gastroenterol; 1993 Mar 22; 7(1):95-128. PubMed ID: 8097414
    [No Abstract] [Full Text] [Related]

  • 40. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.
    Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJ, Långström G, Naesdal J, Scheiman JM, NASA1 SPACE1 Study Group.
    Am J Gastroenterol; 2005 May 22; 100(5):1028-36. PubMed ID: 15842575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.